In a surprising attempt to modernize one of the world’s most prescribed antidepressants, pharmaceutical giant Eli Lilly recently released a new, “enhanced flavor” version of Prozac. But patients and doctors alike have been quick to pan the change, calling the taste revamp a misstep that distracts from the medication’s purpose.
Originally introduced in 1987, Prozac has become synonymous with the treatment of depression and anxiety, valued more for its efficacy than any attention to flavor. But with a new generation of consumers demanding a more “user-friendly” experience, the pharmaceutical company decided it was time to give the iconic green-and-white capsules a palatable twist.
The rollout, however, has been met with disdain. “It’s like they’ve tried to make it taste like some kind of artificially sweetened mint. It’s awful,” said Christine Vaughn, a long-time Prozac user in Seattle. “It’s a serious medication, not a candy.”
Eli Lilly, acknowledging the feedback, stated that the decision was based on focus group results suggesting that a more pleasant taste might improve adherence. “We wanted to reduce the sensory burden of taking daily medication,” a company representative said, “especially for patients who struggle with pill aversion.”
Health professionals, however, are unconvinced. Dr. Martin Yu, a psychiatrist in New York, questioned the necessity of such an adjustment. “Patients weren’t clamoring for a new flavor. They want effective treatment, not a gimmicky taste.” As Eli Lilly considers the feedback, many are left wondering if some changes are better left unmade.
